R&D BIONICE Trademark

Trademark Overview

On Monday, April 17, 2017, a trademark application was filed for R&D BIONICE with the United States Patent and Trademark Office. The USPTO has given the R&D BIONICE trademark a serial number of 79222695. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, August 6, 2018. This trademark is owned by BIONICE, S.L.U.. The R&D BIONICE trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and veterinary active ingredients for treating diseases of the alimentary tract and metabolism; pharmaceutical and veterinary active ingredients for treating diseases of the cardiovascular system; pharmaceutical and veterinary active ingredients for treatment of diseases of the skin; pharmaceutical and veterinary active ingredients for treatment of diseases of the respiratory system; pharmaceutical and veterinary active ingredients for treating diseases of the musculoskeletal system; pharmaceutical and veterinary active ingredients for treating diseases of the nervous system; pharmaceutical preparations, namely, antidepressants; sanitary products for medical use; dietetic food and substances for medical or veterinary use; disinfectants; products for destroying vermin; fungicides, herbicides; chemical preparations for pharmaceutical and veterinary use, namely, for treating diseases of the cardiovascular, respiratory, musculoskeletal and the nervous system; hormones for me...

Custom manufacture of pharmaceutical and veterinary active ingredients for treating diseases of the alimentary tract and metabolism, diseases of the cardiovascular system, diseases of the skin, diseases of the respiratory system, diseases of the musculoskeletal system and diseases of the nervous system; custom manufacture of chemico-pharmaceutical preparations, namely, antidepressants; custom manufacture of sanitary products for medical use; custom manufacture of dietetic food and substances for medical or veterinary use; custom manufacture of disinfectants, products for destroying vermin, fungicides and herbicides; custom manufacture of chemical preparations for pharmaceutical and veterinary use, namely, for treating diseases of the cardiovascular, respiratory, musculoskeletal and the nervous system; custom manufacture of hormones for medical use, steroids and antihistamines; processing of pharmaceutical and chemical products

Pharmaceutical research and development; providing medical research information; providing veterinary research information; conducting clinical trials for others relating to pharmaceutical products; laboratory services, namely, analytical laboratory services; analysis and evaluation of product development; design and development of new technology for others in the field of biotechnology, pharmacy and chemistry; provision of information, advice and consultancy relating to all the aforementioned services
r&d bionice

General Information

Serial Number79222695
Word MarkR&D BIONICE
Filing DateMonday, April 17, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, August 6, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedThe color(s) blue and gray is/are claimed as a feature of the mark.
Description of the Colors ClaimedIt consists in the designation "R&D BioNice". The letters "R&D" and "Bio" are represented in blue, while "Nice" appears in gray.
Goods and ServicesPharmaceutical and veterinary active ingredients for treating diseases of the alimentary tract and metabolism; pharmaceutical and veterinary active ingredients for treating diseases of the cardiovascular system; pharmaceutical and veterinary active ingredients for treatment of diseases of the skin; pharmaceutical and veterinary active ingredients for treatment of diseases of the respiratory system; pharmaceutical and veterinary active ingredients for treating diseases of the musculoskeletal system; pharmaceutical and veterinary active ingredients for treating diseases of the nervous system; pharmaceutical preparations, namely, antidepressants; sanitary products for medical use; dietetic food and substances for medical or veterinary use; disinfectants; products for destroying vermin; fungicides, herbicides; chemical preparations for pharmaceutical and veterinary use, namely, for treating diseases of the cardiovascular, respiratory, musculoskeletal and the nervous system; hormones for medical use; steroids; antihistamines
Goods and ServicesCustom manufacture of pharmaceutical and veterinary active ingredients for treating diseases of the alimentary tract and metabolism, diseases of the cardiovascular system, diseases of the skin, diseases of the respiratory system, diseases of the musculoskeletal system and diseases of the nervous system; custom manufacture of chemico-pharmaceutical preparations, namely, antidepressants; custom manufacture of sanitary products for medical use; custom manufacture of dietetic food and substances for medical or veterinary use; custom manufacture of disinfectants, products for destroying vermin, fungicides and herbicides; custom manufacture of chemical preparations for pharmaceutical and veterinary use, namely, for treating diseases of the cardiovascular, respiratory, musculoskeletal and the nervous system; custom manufacture of hormones for medical use, steroids and antihistamines; processing of pharmaceutical and chemical products
Goods and ServicesPharmaceutical research and development; providing medical research information; providing veterinary research information; conducting clinical trials for others relating to pharmaceutical products; laboratory services, namely, analytical laboratory services; analysis and evaluation of product development; design and development of new technology for others in the field of biotechnology, pharmacy and chemistry; provision of information, advice and consultancy relating to all the aforementioned services

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 15, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, December 15, 2017
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 15, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCRYSTAL PHARMA, S.A.U.
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressES
Party NameBIONICE, S.L.U.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events

Event DateEvent Description
Friday, February 12, 2021CHANGE OF OWNER RECEIVED FROM IB
Friday, August 23, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, August 6, 2019FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, August 6, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, May 24, 2019NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, May 23, 2019NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, May 8, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 8, 2019NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, August 6, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, August 6, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, January 27, 2018REFUSAL PROCESSED BY IB
Saturday, January 6, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, January 6, 2018REFUSAL PROCESSED BY MPU
Tuesday, December 19, 2017APPLICATION FILING RECEIPT MAILED
Saturday, December 16, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 15, 2017NON-FINAL ACTION WRITTEN
Friday, December 15, 2017ASSIGNED TO EXAMINER
Friday, December 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, December 13, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 7, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

bionice diseases pharmaceutical veterinary system active manufacture custom treating ingredients medical